Impact Factor 2020 : 1.545 (@Clarivate Analytics)
  • Users Online: 224
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 11  |  Issue : 11  |  Page : 510-518

Nanoemulsion containing a synergistic combination of curcumin and quercetin for nose-to-brain delivery: In vitro and in vivo studies


R.C.Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist-Dhule (M.S), India

Correspondence Address:
Hitendra S Mahajan
R.C.Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist-Dhule (M.S)
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2221-1691.328058

Get Permissions

Objective: To characterize a nanoemulsion containing a synergistic combination of curcumin (CUR) and quercetin (QUE) for brain targeting through the nose. Methods: The synergistic activity of the combination of two phytoconstituents, curcumin and quercetin (CUR-QUE) was determined at a 2:1 ratio. Nanoemulsions containing the synergistic combination were prepared using high-pressure homogenization technique. Nanoemulsion formulation was characterized for globule size, drug content, thermodynamic stability, zeta potential measurement, and drug release. Histological studies were performed using isolated nasal mucosa of sheep. Moreover, in vivo studies using allograft model were performed. Results: CUR-QUE in a 2:1 ratio combination showed the lowest combination index values 0.99 (combination index<1) for treatment of human glioblastoma U373-MG cell. The combination inhibited the growth of human glioblastoma U373MG cells. The significant drug targeting efficiency percentage (178.25±2.86 for CUR and 170.54±6.11 for QUE) and nose to brain drug direct transport percentage (44.05±0.93 for CUR and 38.25±0.83 for QUE) of optimized nanoemulsion (F9) indicated effective central nervous system targeting via the intranasal route. In vivo anticancer study using allograft model of nude mice demonstrated potential anticancer activity of the synergistic combination of CUR-QUE as compared to doxorubicin. Conclusions: This study demonstrates that synergistic combination of CUR-QUE was optimal for treatment of human glioblastoma. Moreover, significant site-specific delivery to the brain was achieved by administering nanoemulsion through the nose. The study also reveals that intranasal delivery of nanoemulsion containing synergistic combination of CUR and QUE could be a promising strategy for brain tumor treatment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed378    
    Printed10    
    Emailed0    
    PDF Downloaded77    
    Comments [Add]    

Recommend this journal